311
TITLE: New options in hepatocellular carcinoma therapy: the role of gossypol, quercetin and cytochalasin-B. Studies with 18F-FDG  Full Text
AUTHORS: Brito, AF; Verissimo, F; Ribeiro, M; Abrantes, AM ; Castro Sousa, F; Tralhao, JG; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 39
INDEXED IN: WOS
312
TITLE: NEW OPTIONS IN HEPATOCELLULAR CARCINOMA THERAPY: THE ROLE OF QUERCETIN AND CYTOCHALASIN-B
AUTHORS: Fabio Verissimo; Marina Ribeiro; Ana Brito; Ana Abrantes ; Jose Tralhao; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
313
TITLE: Novel In-111-estradiol based complexes: preclinical evaluation for oestrogen positive tumour targeting  Full Text
AUTHORS: Cunha, S; Vultos, F; Fernandes, C; Oliveira, MC; Maria Filomena Botelho ; Santos, I; Gano, L;
PUBLISHED: 2012, SOURCE: 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 39
INDEXED IN: WOS
314
TITLE: Old and new radiopharmaceuticals for PET: what is the role of 18F-FDG and 18F-CHO in prostate cancer?  Full Text
AUTHORS: Pedrosa, L; Abrantes, AM ; Mamede, AC; Teixo, RJ; Pires, AS ; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 39
INDEXED IN: WOS
315
TITLE: Prostate Cancer - What Happens Beyond the Limits of Oxygen?  Full Text
AUTHORS: Pedrosa, L; Abrantes, AM ; Mamede, AC; Pires, AS ; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 22nd Biennial Congress of the European-Association-for-Cancer-Research in EUROPEAN JOURNAL OF CANCER, VOLUME: 48
316
TITLE: Quercetin and Cytochalasin-B - New Options in Hepatocellular Carcinoma Therapy?  Full Text
AUTHORS: Verissimo, F; Ribeiro, M; Brito, AF; Abrantes, AM ; Tralhao, JG; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: 22nd Biennial Congress of the European-Association-for-Cancer-Research in EUROPEAN JOURNAL OF CANCER, VOLUME: 48
INDEXED IN: WOS
317
TITLE: Radiolabelling of ascorbic acid: A new clue to clarify its action as an anticancer agent?
AUTHORS: Mamede, AC; Abrantes, AM ; Pires, AS ; Tavares, SD; Serra, ME ; Maia, JM; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: Current Radiopharmaceuticals, VOLUME: 5, ISSUE: 2
INDEXED IN: Scopus CrossRef: 3
318
TITLE: Radiopharmaceuticals for Bone Metastasis Therapy and Beyond: A Voyage from the Past to the Present and a Look to the Future
AUTHORS: Sara Ferreira; Irene Dormehl; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, VOLUME: 27, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 13
319
TITLE: Radiopharmaceuticals: Pre-Clinical evaluation
AUTHORS: Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: Current Radiopharmaceuticals, VOLUME: 5, ISSUE: 2
INDEXED IN: Scopus CrossRef
320
TITLE: Radiotracers in oncology
AUTHORS: Maria Filomena Botelho ; Abrantes, AM ;
PUBLISHED: 2012, SOURCE: Current Radiopharmaceuticals, VOLUME: 5, ISSUE: 2
INDEXED IN: Scopus CrossRef: 1
Page 32 of 50. Total results: 500.